Therapy News and Research

RSS

Diets rich in potassium may help prevent heart and kidney problems in patients with type 2 diabetes

Diets rich in potassium may help protect the heart and kidney health of patients with type 2 diabetes, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.

13 Nov 2015

TGen: PPF drug could help treat patients with deadly brain cancer

In a significant breakthrough, the Translational Genomics Research Institute has identified a drug, propentofylline or PPF, that could help treat patients with deadly brain cancer.

13 Nov 2015

Less effective drugs can help beat malaria more effectively

Oxford University scientists have found that the more effective way to beat malaria is to use less effective drugs some of the time.

13 Nov 2015

Drug combination produces long-term responses in patients with mantle cell lymphoma

New research from Moffitt Cancer Center and its collaborators find that the drug combination rituximab plus lenalidomide was effective and produced long-term responses in patients with mantle cell lymphoma.

13 Nov 2015

Anxiety associated with poor asthma outcomes

Anxiety sensitivity, in simple terms, is a fear of fear. But when people with anxiety sensitivity also have asthma, their suffering can be far more debilitating and dangerous, because they have difficulty managing their asthma. A new study explores this issue and recommends treatment to help decrease asthma symptoms.

13 Nov 2015

Johns Hopkins researchers present new healthcare tips from American Heart Association Meeting

Linking digital activity trackers to smartphones and periodically pinging users with personalized texts that urge them to walk more can significantly increase physical activity levels and spark healthy behavior changes, according to findings of a pilot study conducted at Johns Hopkins.

13 Nov 2015

PT Solutions announces opening of new facility in Atlanta's Morningside neighborhood

PT Solutions, a physical therapy practice that offers a comprehensive suite of therapeutic services, has announced the opening of PT Solutions of Morningside in the city of Atlanta (549 Amsterdam Avenue).

12 Nov 2015

Some antibiotics may make MRSA more harmful

Treating MRSA with certain first-line antibiotics can actually make MRSA skin infections worse, according to a study published in Cell Host & Microbe.

12 Nov 2015

CHOP researchers delay symptoms, extend lifespan in animal model of Batten disease

Researchers have taken a significant step forward in developing gene therapy against a fatal neurodegenerative disease that strikes children. By delivering a working version of a gene to produce a key enzyme that is lacking in Batten disease, the scientists delayed symptoms and extended lifespan in dogs with a comparable disease.

12 Nov 2015

Moffitt Cancer Center study finds link between common gene mutations and tumor immune surveillance

Learning if a lung cancer patient has genetic mutations can help oncologists determine the best approach to treatment. There are four gene mutations (KRAS, TP53, STK11, and EGFR) that most commonly occur in lung cancer; however, there are limited effective therapies to target these mutations. With this in mind, Moffitt Cancer Center performed an extensive genetic analysis of lung cancer specimens to unravel how mutations in the two of those genes (TP53 and STK11) contribute to the biology of lung cancer and patient outcomes.

12 Nov 2015

Researchers demonstrate new screening model to identify drug targets for the most lethal strain of malaria

A University of South Florida Center for Global Health & Infectious Diseases Research team has demonstrated a new screening model to classify antimalarial drugs and to identify drug targets for the most lethal strain of malaria, Plasmodium falciparum.

12 Nov 2015

OCD patients can benefit from exposure and response prevention therapy when drug treatment options fail

Patients with Obsessive-Compulsive Disorder (OCD) can improve their symptoms significantly by adding exposure and response prevention therapy to their treatment regimen when common drug treatment options have failed, according to new research from psychiatrists at the Perelman School of Medicine at the University of Pennsylvania.

12 Nov 2015

Computerised cognitive behavioural therapy likely to be ineffective in depression treatment

Researchers at the University of York have revealed computerised cognitive behavioural therapy (cCBT) is likely to be ineffective in the treatment of depression.

12 Nov 2015

Intravenous PEG-asparaginase use recommended in paediatric ALL

Phase III trial results support the use of intravenously administered PEGylated Escherichia coli asparaginase as the preparation of choice in children and adolescents with acute lymphoblastic leukaemia.

11 Nov 2015

Tocilizumab drug offers potential treatment for patients with polymyalgia rheumatics

A drug approved to treat rheumatoid arthritis, tocilizumab (Actemra, Genentech), is a potential new therapy for patients with polymyalgia rheumatica, according to an open-label, phase II study presented at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals on November 10.

11 Nov 2015

Phase I clinical trial shows investigational anticancer therapeutic is safe, tolerable in lymphoma patients

Results from a phase I clinical trial showed that the first-in-class, investigational, anticancer therapeutic pevonedistat was safe, tolerable, and had some anticancer activity in heavily pretreated patients with relapsed/refractory lymphoma.

11 Nov 2015

New data validates use of ActiveCare DVT prophylaxis compression system following total joint replacement surgery

Medical Compression Systems, Inc. (MCS), today announced new data further validating the use of the ActiveCare DVT prophylaxis compression system following total joint replacement procedures.

11 Nov 2015

Mallinckrodt Study Shows Acthar® Reduces Disease Activity in Patients with Persistently Active Systemic Lupus Erythematosus

Data presented yesterday by researchers for Mallinckrodt plc, a leading specialty biopharmaceutical company, suggest that H.P. Acthar® Gel (repository corticotropin injection) reduces certain measures of disease activity in patients with persistently active Systemic Lupus Erythematosus (SLE) who are receiving corticosteroid therapy.

10 Nov 2015

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

New Haven Pharmaceuticals, Inc. today announced new study data that shows the company's FDA-approved drug DURLAZA delivers sustained antiplatelet control for a full 24-hour period in high-risk patients.

10 Nov 2015

New findings reveal association between colorectal cancer and melanoma drug treatment

Veteran cancer reseacher Prof. Emeritus Alexander Levitzki of Hebrew University of Jerusalem says new findings show link between colorectal cancer and melanoma drug treatment knoqwn as "NT157" in two recently published studies in journal, "Ocogene."

10 Nov 2015

Therapy News and Research

Diets rich in potassium may help prevent heart and kidney problems in patients with type 2 diabetes

TGen: PPF drug could help treat patients with deadly brain cancer

Less effective drugs can help beat malaria more effectively

Drug combination produces long-term responses in patients with mantle cell lymphoma

Anxiety associated with poor asthma outcomes

Johns Hopkins researchers present new healthcare tips from American Heart Association Meeting

PT Solutions announces opening of new facility in Atlanta's Morningside neighborhood

Some antibiotics may make MRSA more harmful

CHOP researchers delay symptoms, extend lifespan in animal model of Batten disease

Moffitt Cancer Center study finds link between common gene mutations and tumor immune surveillance

Researchers demonstrate new screening model to identify drug targets for the most lethal strain of malaria

OCD patients can benefit from exposure and response prevention therapy when drug treatment options fail

Computerised cognitive behavioural therapy likely to be ineffective in depression treatment

Intravenous PEG-asparaginase use recommended in paediatric ALL

Tocilizumab drug offers potential treatment for patients with polymyalgia rheumatics

Phase I clinical trial shows investigational anticancer therapeutic is safe, tolerable in lymphoma patients

New data validates use of ActiveCare DVT prophylaxis compression system following total joint replacement surgery

Mallinckrodt Study Shows Acthar® Reduces Disease Activity in Patients with Persistently Active Systemic Lupus Erythematosus

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

New findings reveal association between colorectal cancer and melanoma drug treatment

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News